1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Albiglutide
Trade Name:
Eperzan
Manufacturer/Distributor:
Glaxosmithkline Inc
ca.gsk.com
Classification:
Antihyperglycemic agent
ATC Class:
A10BX - other blood glucose lowering drugs, excluding insulin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2015/07/15
Date Marketed in Canada (yyyy/mm/dd):
2016/02/19
Presentation:
Powder for solution: 30 mg/0.5 mL. DIN: 02443635
Powder for solution: 50 mg/0.5 mL. DIN: 02443643
Comments:
Albiglutide is an analog of human glucagon-like peptide 1 (GLP-1) and acts as a GLP-1 receptor agonist. It is indicated for once-weekly administration for treatment of adults with type 2 diabetes, as an adjunct to diet and exercise.
Back to:
Drug Product Listings 
